Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Bone marrow transplantation--the Marsden experience.

C Tiley1, R Powles

  • 1Leukemia Unit, Royal Marsden Hospital, Sutton, United Kingdom.

Clinical Transplants
|January 1, 1990
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Melphalan exposure and outcome in obese and non-obese adults with myeloma. A study of pharmacokinetics and pharmacodynamics.

Bone marrow transplantation·2020
Same author

COORDINATION OF MANAGEMENT OF THE ACUTE RADIATION SYNDROME.

Radiation protection dosimetry·2018
Same author

Acute Myeloid Leukaemia Following Matched Allogeneic Bone Marrow Transplantation for T-Cell Lymphoblastic Lymphoma.

Leukemia & lymphoma·2016
Same author

International Myeloma Working Group recommendations for global myeloma care.

Leukemia·2013
Same author

Ex vivo release of GABA from tetanus toxin-induced chronic epileptic foci decreased during the active seizure phase.

Neurochemistry international·2010
Same author

Nonlinear rotation of three-dimensional dark spatial solitons in a Gaussian laser beam.

Optics letters·2009

Melphalan with TBI conditioning shows promising results for leukemia relapse after transplantation. Further research is needed to optimize GvHD prophylaxis and explore cytokine combinations for improved outcomes.

Area of Science:

  • Hematology
  • Oncology
  • Transplantation Medicine

Background:

  • Leukemic relapse is a significant challenge following autologous and allogeneic stem cell transplantation.
  • Current conditioning regimens require optimization to improve disease-free survival and reduce relapse rates.

Purpose of the Study:

  • To evaluate the efficacy of Melphalan combined with Total Body Irradiation (Melph/TBI) as a conditioning regimen in leukemia patients undergoing transplantation.
  • To compare the antileukemic activity of Melph/TBI versus Cyclophosphamide with TBI (Cy/TBI) in Acute Myeloid Leukemia (AML).
  • To investigate the role of Graft-versus-Host Disease (GvHD) in the antileukemic effect of Melph/TBI in AML.

Main Methods:

  • A single-arm study assessed Melph/TBI in patients with Acute Lymphoblastic Leukemia (ALL) undergoing autograft.

Related Experiment Videos

  • A comparative study evaluated Cy/TBI versus Melph/TBI in AML patients.
  • A retrospective analysis compared Melph/TBI in autologous versus allogeneic transplantation for AML.

    • Main Results:

    • Melph/TBI demonstrated encouraging disease-free survival in ALL patients, comparable to other conditioning regimens.
    • Melph/TBI showed significantly increased antileukemic activity in AML compared to Cy/TBI.
    • The antileukemic effect of Melph/TBI in AML appears to be associated with GvHD, particularly in the allogeneic setting.

    Conclusions:

    • Melph/TBI is a promising conditioning regimen for leukemia transplantation, warranting further randomized studies.
    • Optimizing GvHD prophylaxis intensity may reduce Melph/TBI toxicity while preserving its antileukemic effect.
    • Granulocyte-macrophage colony-stimulating factor (GM-CSF) did not demonstrate clinical benefit despite facilitating neutrophil recovery.